- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05435105
Effects of Virtual Reality, Cold-Vibration Due To Intravenous Catheterization on Pain, Fear and Anxiety on Children
June 22, 2022 updated by: Berfu Atalay, Akdeniz University
The Effect of Virtual Reality and Local Cold-Vibration Methods on Reducing Anxiety, Fear and Pain Due to Peripheral Intravenous Catheterization in Children
This is a randomized controlled trial.
The aim of the study is to the effects of Virtual Reality and Local Cold-Vibration applications in reducing anxiety, fear and pain due to intravenous catheterization (PIC) in children aged 5-10 years.
PIC was found to be effective in reducing anxiety, fear and pain due to peripheral intravenous catheterization.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Peripheral intravenous catheterization is an administration method that is frequently used in children and causes pain.
There are different non-pharmacological methods for reducing pain due to invasive procedures.
The use of non-pharmacological methods is an important part of nursing care to reduce the short and long-term negative effects of painful interventions on children.This study was planned to compare the effectiveness of virtual reality and local cold-vibration applications in reducing anxiety, fear and pain caused by PIC in children aged 5-10 years.
It was planned as a randomized controlled experimental study in pre-test, post-test design.
The sample of the study was carried out in the Pediatric Emergency Unit of Akdeniz University Medical Faculty Hospital.
The applicant will consist of 120 children aged 5-10 years.
There will be a total of three groups in the research, 2 of which are the intervention group (virtual reality, local cold-vibration) and the control group (routine application).
Data will be collected using the "Child-Parent Description Form", "Child Anxiety Scale-State Scale", "Child Fear Scale", "Wong- Baker Faces Pain Scale".
Data will be collected before and within the first 5 minutes after IM injection administration.
Scales; to be filled in separately by the child, one of the parents, and the nurse administering the PIC.
As a result of this study, it was concluded that the use of virtual reality glasses and local cold-vibration methods are effective in reducing the pain, anxiety and fear that due to PIC placement in children aged 5-10 years.
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Akdeniz University
-
Antalya, Akdeniz University, Turkey, 07058
- Aysegul ISLER DALGIC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
the child;
- between the ages of 5-10
- PIC application will be made
- No visual, auditory or sensory loss
- Mental and language deficiencies
- Those who have not taken any analgesic medication in the last 4 hours
- Do not have a chronic disease (such as oncological diseases, chronic kidney failure) that causes repeated admissions or hospitalizations to the hospital.
Exclusion Criteria:
- Unsuccessful PIC application in the first time
- The child in the group with local cold-vibration application removes the device during the procedure (PIC application).
- The child in the group in which virtual reality was applied, removing the virtual reality glasses during the procedure (PIC application).
- Suspecting 'Covid 19' (having any of the symptoms such as fever, cough, respiratory distress, chest pain, loss of taste and smell, sore throat)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality Group
Watching the cartoon by wearing virtual reality glass to the child during the peripheral intravenous catheterization
|
Distraction method
|
Experimental: Local Cold-Vibration Group
The local cold-vibration device is placed 5 cm above the area just before peripheral intravenous catheterization
|
Distraction method
|
No Intervention: Control Group
Routine Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessing the children's anxiety with Children's State Anxiety
Time Frame: Before the peripheral intravenous catheterization
|
The Children's State Anxiety (CAS-S).
The CAS-S assesses children's anxiety and uses before medical procedures.
This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10).
This scale ranges from 0 to 10. Higher values represent higher anxiety
|
Before the peripheral intravenous catheterization
|
Assessing the children's anxiety with Children's State Anxiety
Time Frame: Within the first 5 minutes after the peripheral intravenous catheterization
|
The Children's State Anxiety (CAS-S).
The CAS-S assesses children's anxiety and uses before medical procedures.
This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10).
This scale ranges from 0 to 10. Higher values represent higher anxiety
|
Within the first 5 minutes after the peripheral intravenous catheterization
|
Assessing the children's fear with Child Fear Scale
Time Frame: Before the peripheral intravenous catheterization
|
The Child Fear Scale (CFS).
The Child Fear Scale will use.This one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear.
This rating scale ranges from 0 to 4. It ranges from a no fear (neutral) face (0) on the far left to a face showing extreme fear on the far right.
Higher scores mean a worse outcome.
The rater responds indicates the level of fear.
|
Before the peripheral intravenous catheterization
|
Assessing the children's fear with Child Fear Scale
Time Frame: Within the first 5 minutes after the peripheral intravenous catheterization
|
The Child Fear Scale (CFS).
The Child Fear Scale will use.This one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear.
This rating scale ranges from 0 to 4. It ranges from a no fear (neutral) face (0) on the far left to a face showing extreme fear on the far right.
Higher scores mean a worse outcome.
The rater responds indicates the level of fear.
|
Within the first 5 minutes after the peripheral intravenous catheterization
|
Assessing the children's pain with Wong-Baker-FACES
Time Frame: Before the peripheral intravenous catheterization
|
Wong-Baker FACES (WB-FACES) Pain Rating Scale used.
This scale uses in children aged 3 and older to rate pain severity.
This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/ no pain) to crying (10 = hurts worst).
|
Before the peripheral intravenous catheterization
|
Assessing children's pain with Wong-Baker-FACES
Time Frame: Within the first 5 minutes after the peripheral intravenous catheterization
|
Wong-Baker FACES (WB-FACES) Pain Rating Scale used.
This scale uses in children aged 3 and older to rate pain severity.
This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/ no pain) to crying (10 = hurts worst).
|
Within the first 5 minutes after the peripheral intravenous catheterization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Aysegul ISLER DALGIC, Professor, Akdeniz University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
December 27, 2021
Study Completion (Anticipated)
June 27, 2022
Study Registration Dates
First Submitted
June 17, 2022
First Submitted That Met QC Criteria
June 22, 2022
First Posted (Actual)
June 28, 2022
Study Record Updates
Last Update Posted (Actual)
June 28, 2022
Last Update Submitted That Met QC Criteria
June 22, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/881
- 5208 (Other Identifier: AkdenizU Scientific Research Projects Coordination Unit)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fear
-
NYU Langone HealthCompleted
-
Cairo UniversityUnknownInjection Fear, Fear, Avoidance, Dental
-
Cukurova UniversityCompletedPregnancy | Fear | Education | Fear of Childbirth | BirthTurkey
-
KK Women's and Children's HospitalRecruitingAnxiety | Pregnancy Related | Fear | Fear of Childbirth | Anxiety and FearSingapore
-
Fundacion Miguel ServetUniversidad Pública de NavarraCompleted
-
University of GuelphNatural Sciences and Engineering Research Council, CanadaRecruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Enrolling by invitation
-
New York UniversityCompleted
-
Riyadh Colleges of Dentistry and PharmacyCompleted
Clinical Trials on Virtual reality
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Gustave Roussy, Cancer Campus, Grand... and other collaboratorsTerminated
-
Hacettepe UniversityRecruitingGonarthrosis; PrimaryTurkey